ARTICLE | Clinical News
Accurun 644 Control regulatory update
July 4, 2011 7:00 AM UTC
SeraCare received CE Mark approval for its Accurun 644 Control cystic fibrosis (CF) diagnostic. The test, which identifies mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) ...